Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | -15 |
| Ticker | SPL |
| Latest Price | 0.09 AUD as of close on 04-Jul-2025 |
| 3 Month price range | 0.09 to 0.10 AUD |
| Market Capitalisation | 37.64Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of dendrimer enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; SPL7013 for vaginal gel; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia. See More ... |
| Company URL | https://starpharma.com |
| See Darwins Full Analysis for Starpharma Holdings Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Starpharma Holdings Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -5 |
| Sentiment | News and Candle Patterns. | +1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -2 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -9 |
There are 4 live alerts for Starpharma Holdings Ltd.
There are 6 peers of Starpharma Holdings Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Cann Group Ltd (CAN) | Pharmaceuticals | +30.8 | 0 |
| Ecofibre Ltd (EOF) | Pharmaceuticals | 0 | -8 |
| Firebrick Pharma Ltd (FRE) | Pharmaceuticals | -6.0 | -12 |
| Mayne Pharma Group Ltd (MYX) | Pharmaceuticals | +3.5 | -15 |
| Medical Developments International Ltd (MVP) | Pharmaceuticals | -2.0 | +9 |
| Neuren Pharmaceuticals Ltd (NEU) | Pharmaceuticals | +2.7 | +42 |
To see complete information on Starpharma Holdings Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |